Comparison of baseline characteristics among titration groups (consented patients) and between consented and non-consented patients
| Baseline characteristic | Consented (n=249) | p Value* | Non-consented (n=63) | p Value | ||
| Manual (n=83) | Laboratory APAP (n=80) | Home APAP (n=86) | ||||
| Male sex, n(%) | 62 (75) | 51 (64) | 59 (69) | 0.3 | 47 (75) | 0.4 |
| Age, years | 50±12 | 53±10 | 50±12 | 0.2 | 51±13 | 0.8 |
| Height, m | 1.72±0.1 | 1.72±0.1 | 1.71±0.1 | 0.8 | 172±0.1 | 0.6 |
| Weight, kg | 96±18 | 98±17 | 94±17 | 0.4 | 96±18 | 0.9 |
| BMI, kg/m2 | 32.4±5.7 | 33.4±5.3 | 32.2±5.2 | 0.3 | 32.8±6.0 | 0.8 |
| Epworth Sleepiness Score | 14.1±4.0 | 12.9±3.5 | 13.8±4.1 | 0.13 | 13.8±4,5 | 0.7 |
| AHI, events/h slept | 38 (27–63) | 44 (29–63) | 38 (26–55) | 0.3 | 43 (28–71) | 0.2 |
| Time oxygen saturation <90%, min | 5 (0–31) | 6 (0–25) | 2 (0–19) | 0.16 | 2 (0–44) | 0.6 |
| Hypertension, n (%) | 28 (34) | 33 (41) | 25 (29) | 0.3 | 20 (32) | 0.7 |
| Ischaemic heart disease, n (%) | 7 (8) | 6 (8) | 5 (6) | 0.8 | 2 (3) | 0.4 |
| Type 2 diabetes, n (%) | 9 (11) | 9 (11) | 13 (15) | 0.6 | 10 (16) | 0.5 |
| Hypercholesterolaemia, n (%) | 14 (17) | 19 (24) | 18 (21) | 0.5 | 11 (17) | 0.6 |
Data are presented as mean±SD, median (IQR) or number (%).
Comparisons of consented with non-consented (refused or missed) patients.
↵* Comparisons of titration groups among consented patients.
AHI, apnoea+hypopnoea index; APAP, automatic positive airway pressure; BMI, body mass index.